市場調查報告書

全球子宮內避孕器(IUD)市場:成長,趨勢,預測

Intrauterine Contraceptive Devices (IUD) Market - Growth, Trends, and Forecast (2019 - 2024)

出版商 Mordor Intelligence LLP 商品編碼 390737
出版日期 內容資訊 英文 115 Pages
商品交期: 2-3個工作天內
價格
全球子宮內避孕器(IUD)市場:成長,趨勢,預測 Intrauterine Contraceptive Devices (IUD) Market - Growth, Trends, and Forecast (2019 - 2024)
出版日期: 2019年04月01日內容資訊: 英文 115 Pages
簡介

本報告提供全球子宮內避孕器(IUD)市場相關調查,市場趨勢與今後的成長預測,各類型,各產品,各地區趨勢,及打入市場的主要企業簡介等彙整資料。

第1章 簡介

第2章 調查方法

第3章 摘要整理

第4章 主要推論

第5章 市場概要與產業趨勢

  • 目前市場方案
  • 技術概要
  • 治療的最新趨勢
  • 投資分析
  • 波特五力分析

第6章 促進要素,阻礙要素,機會,課題分析

  • 推動市場的要素
  • 阻礙市場的要素
  • 市場機會
  • 主要課題

第7章 市場區隔

  • 各類型
    • 荷爾蒙IUD
    • 銅IUD
  • 各產品
    • MIRENA
    • SKYLA
    • PARAGARD
    • ESSURE
    • LEVOSERT
    • 其他

第8章 各地區市場:各地區佔有率及預測

  • 北美
  • 歐洲
  • 亞太地區
  • 中東、非洲
  • 南美

第9章 競爭環境

  • 合併、收購
  • 協定、聯合、聯盟
  • 新產品上市

第10章 主要供應商

第11章 投資的機會相關分析師的見解

第12章 市場未來發展預測

第13章 附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: 53797

Market Overview

  • The major factors for the growth of the intrauterine contraceptive devices (IUD) market include the technological innovations leading to effective contraception and fewer side effects, increasing rate of unintended pregnancies, and supportive government initiatives and private firms for the prevention of unwanted abortions and pregnancies.
  • Unintended pregnancy is an undesired conception. Not using contraception or incorrect use of contraceptive methods can result in unintended pregnancy. The percentage of unintended pregnancies is highest in teens younger than 18 years, followed by women in the age group of 20 to 24 years. The World Health Organization stated that every year around 87 million pregnancies occur unintentionally. These unintentional pregnancies are directly contributing to the raised demand for contraceptive devices.
  • A report from the Office of Disease Prevention and Health Promotion (ODPHP) stated that more than half of pregnancies are unplanned in the United States, i.e., about 51% of the 6.6 million pregnancies are unintended. In earlier years, more than 50% of such pregnancies ended in abortion. However, over the past few years, the awareness on contraception has contributed to both the decline in unplanned pregnancies and the growth of the contraception market. Family planning efforts, which include increasing access to intrauterine contraceptive devices, can help reduce unintended pregnancies. The use of IUDs decreased the proportion of births that were unplanned. The usage of IUD is increasing year on year as women find IUD the most convenient, safe, and effective form of contraception. Therefore, the market studied is expected to be driven by the increasing unintended pregnancies, worldwide.

Scope of the Report

As per the scope of this report, an intrauterine device (IUD or coil) is a small contraceptive device, often 'T'-shaped, containing either copper or levonorgestrel, which is inserted into the uterus. It is one form of long-acting reversible contraception, which is the most effective type of reversible birth control. IUDs are highly effective, have minimal systemic effects, and involve only one contraceptive decision every three, five, or 10 years depending on the IUD chosen. Types include hormone-releasing IUDs (effective for 3 years or 5 years, depending on the type) and a copper-bearing IUD (effective for 10 to 12 years).

Key Market Trends

The Copper Intrauterine Device Segment is Expected to Account for the Largest Market Share During the Forecast Period

Copper IUDs have been in the market for a long time, since about 1988, earlier than the hormonal IUDs. Paragard used to be marketed by Teva Pharmaceuticals since the year 2016 but in the year 2017, the company sold its Paragard division to CooperSurgical. However, Paragard was approved in the year 1984 and is available in the United States since the year 1988. It releases copper ions that are toxic to the sperm and prevents fertilization. They are usable for up to 10 years. Paragard was the only copper IUD available in many countries, including the United States, till 2015. One of the advantages of using copper IUDs is that they can be used as emergency contraceptives. They can be used within five days of unprotected intercourse to prevent pregnancy. Unlike the hormonal IUD, where the user has to wait for two days for the IUD to take effect, copper IUDs are functional immediately after insertion. They are also less expensive in comparison to hormonal IUDs. The copper IUDs are expected to observe a steady growth, during the forecast period.

North America is Expected to Dominate the Global Market

IUDs are one of the most effective forms of reversible contraception, and the interest in this method is growing among women and healthcare providers. The US market has shown the greatest demand in the use of both hormone-free copper, as well as hormone-based IUDs. It is the primary form of contraceptives used among the female US citizens. Because of its role as an emergency contraceptive, the market is witnessing a stiff increase in its demand. Hormonal IUDs are also trending in the US market, which is approved by the FDA. The three most common types of hormonal IUDs available and trending in the US market are Mirena, Skyla, and Liletta. The American College of Obstetricians and Gynecologists has now developed new guidelines to make IUDs popular among patients. It has been endorsed by the American Academic of Pediatrics as the first line of contraceptive option for teenage girls. Thus, owing to the presence of better healthcare infrastructure and awareness among the population, the North American intrauterine contraceptive devices (IUD) market is expected to grow during the forecast period.

Competitive Landscape

The market studied is consolidated, owing to the presence of a few major market players. Some of the market players are Allergan PLC, Bayer AG, CooperSurgical Inc., DKT International, Egemen International, Mona Lisa NV, Pregna International Limited, Prosan International BV, and SMB Corporation of India.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • Report customization as per the client's requirements
  • 3 months of analyst support

Table of Contents

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Technological Innovations Leading to Effective Contraception and Less Side Effects
    • 4.2.2 Increasing Rate of Unintended Pregnancies
    • 4.2.3 Supportive Government Initiatives and Private Firms for the Prevention of Unwanted Abortions and Pregnancies
  • 4.3 Market Restraints
    • 4.3.1 Risk of Causing Pelvic Inflammatory Infection (PID)
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Type
    • 5.1.1 Hormonal Intrauterine Device
    • 5.1.2 Copper Intrauterine Device
  • 5.2 By End User
    • 5.2.1 Hospitals
    • 5.2.2 Gynecology Clinics
    • 5.2.3 Community Health Care Centers
    • 5.2.4 Other End Users
  • 5.3 Geography
    • 5.3.1 North America
      • 5.3.1.1 US
      • 5.3.1.2 Canada
      • 5.3.1.3 Mexico
    • 5.3.2 Europe
      • 5.3.2.1 Germany
      • 5.3.2.2 UK
      • 5.3.2.3 France
      • 5.3.2.4 Italy
      • 5.3.2.5 Spain
      • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia-Pacific
      • 5.3.3.1 China
      • 5.3.3.2 Japan
      • 5.3.3.3 India
      • 5.3.3.4 Australia
      • 5.3.3.5 South Korea
      • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle East & Africa
      • 5.3.4.1 GCC
      • 5.3.4.2 South Africa
      • 5.3.4.3 Rest of Middle East & Africa
    • 5.3.5 South America
      • 5.3.5.1 Brazil
      • 5.3.5.2 Argentina
      • 5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Allergan PLC
    • 6.1.2 Bayer AG
    • 6.1.3 CooperSurgical Inc.
    • 6.1.4 DKT International
    • 6.1.5 Egemen International
    • 6.1.6 Mona Lisa NV
    • 6.1.7 Pregna International Limited
    • 6.1.8 Prosan International BV
    • 6.1.9 SMB Corporation of India

7 MARKET OPPORTUNITIES AND FUTURE TRENDS